BeiGene (NASDAQ: BGNE; HKG: 6160; SHA: 688235), a global biotechnology company, has announced the inauguration of its flagship facility in Hopewell, New Jersey, located within the Princeton West Innovation Campus. The establishment of BeiGene’s USD 800 million plant represents the successful conclusion of a three-year expansion initiative aimed at enhancing the company’s integrated manufacturing and research and development capabilities in the United States.
The new facility is expected to create hundreds of skilled high-tech jobs by the end of 2025, contributing to the local economy and advancing the company’s commitment to innovation. Equipped with cutting-edge biologics manufacturing capabilities, the site also includes a clinical research and development center, which will play a pivotal role in reinforcing BeiGene’s position as a leader in oncology research and development.- Fineline.com
